- PR Newswire•23 days ago
CALGARY, Nov. 10, 2016 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (ONC.TO) (ONCYF) (ONY.F) today announced the appointment of Andres A. Gutierrez, MD, PhD to the role of Chief Medical Officer. "Dr. Gutierrez's significant immuno-oncology experience will be transformative to Oncolytics. His expertise spans a range of indications and drug types that are immediately applicable to his new role and the clinical programs at Oncolytics," said Dr. Matt Coffey, Interim President and CEO of Oncolytics Biotech.
- Associated Press•last month
On a per-share basis, the Calgary, Alberta-based company said it had a loss of 2 cents. The company's shares closed at 21 cents. A year ago, they were trading at 35 cents. _____ This story was generated ...
ONC.TO : Summary for ONCOLYTICS BIO - Yahoo Finance
Oncolytics Biotech Inc. (ONC.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.19 - 0.21|
|52 Week Range||0.19 - 0.75|
|PE Ratio (TTM)||-1.86|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|